Page - 1 of 1


HIVsir IDHIV StrainNCBI AccessionTarget GenePosition of siRNA targetSense Sequence of siRNAEfficacy (%)Target Conservation *Cell linePubMed
1013HIV-1 (IIIB)EU541617GagK*1475GAGAACCAAGGGGAAGUGACA75.00711(47.53%)293 T12391237
1014HIV-1 (IIIB)EU541617GagK*896GGGCAAGCAGGGAGCUAGAAC89.00331(22.13%)293 T12391237
1003HIV-1 (IIIB)EU541617Gag1608GAUUGUACUGAGAGACAGGCU76.00183(12.23%)Hela12042777
1015HIV-1 (IIIB)EU541617LTRK*9215GAUGGUGCUACAAGCUAGUAC94.0050(3.34%)293 T12391237
1063HIV-1 (IIIB)EU541617NefN/AGCGUCGACGGCAAGUGGUCAAAACGUA48.300(0.00%)MT-4 T/Jurkat T15601474
1064HIV-1 (IIIB)EU541617NefN/AGCGUCGACGCCAGCAGCAGAUGGGGUG36.501(0.07%)MT-4 T/Jurkat T15601474
1065HIV-1 (IIIB)EU541617NefN/AGCGUCGACGUGCCUGGCUAGAAGCACA78.401(0.07%)MT-4 T/Jurkat T15601474
1066HIV-1 (IIIB)EU541617NefN/AGCGUCGACGCACAAGAGGAGGAGA70.900(0.00%)MT-4 T/Jurkat T15601474
1067HIV-1 (IIIB)EU541617NefN/AGCGUCGACGACUGGAAGGGCUAAUUUG50.500(0.00%)MT-4 T/Jurkat T15601474
1068HIV-1 (IIIB)EU541617NefN/AGCUCGACGGCUACUUCCCUGAUUGGC65.500(0.00%)MT-4 T/Jurkat T15601474
1069HIV-1 (IIIB)EU541617NefN/AGCGUCGACGGUAGAAGAGGCCAAUGAA58.000(0.00%)MT-4 T/Jurkat T15601474
1070HIV-1 (IIIB)EU541617NefN/AGCGUCGACGCAUUUCAUCACAUGGCCC48.302(0.13%)MT-4 T/Jurkat T15601474
1525HIV-1 (IIIB)EU541617LTRN/AGGGACUUUCCGCUGGGGAC0.00438(29.28%)MAGIC-519771207
1585HIV-1 (IIIB)EU541617GagK*2062GAUUGUACUGAGAGACAGG88.00197(13.17%)Hela15831707
1575HIV-1 (IIIB)EU541617vifK*5195GUUCAGAAGUACACAUCCC80.00797(53.28%)Hela15831707
1574HIV-1 (IIIB)EU541617GagK*2062GAUUGUACUGAGAGACAGG91.00197(13.17%)Hela15831707
1573HIV-1 (IIIB)EU541617revK*8485GGCACUUAUCUGGGACGAU96.002(0.13%)Hela15831707